SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-21-000813
Filing Date
2021-09-16
Accepted
2021-09-16 09:00:22
Documents
12
Period of Report
2021-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 43865
  Complete submission text file 0001553350-21-000813.txt   217910

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE htbx-20210915.xsd EX-101.SCH 3039
3 XBRL LABEL FILE htbx-20210915_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE htbx-20210915_pre.xml EX-101.PRE 22368
5 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 3603
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 211257028
SIC: 2834 Pharmaceutical Preparations